potassium phosphates

Generic: potassium phosphate, monobasic potassium phosphate, dibasic

Labeler: fresenius kabi usa, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name potassium phosphates
Generic Name potassium phosphate, monobasic potassium phosphate, dibasic
Labeler fresenius kabi usa, llc
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

dibasic potassium phosphate 236 mg/mL, monobasic potassium phosphate 224 mg/mL

Manufacturer
Fresenius Kabi USA, LLC

Identifiers & Regulatory

Product NDC 65219-056
Product ID 65219-056_935c5395-1f0b-4277-97de-8b1cf1252d1e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA212832
Listing Expiration 2026-12-31
Marketing Start 2020-02-10

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65219056
Hyphenated Format 65219-056

Supplemental Identifiers

RxCUI
1928567 1928569 2667657
UPC
0365219056096 0365219052098 0365219054092
UNII
4J9FJ0HL51 CI71S98N1Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name potassium phosphates (source: ndc)
Generic Name potassium phosphate, monobasic potassium phosphate, dibasic (source: ndc)
Application Number NDA212832 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 236 mg/mL
  • 224 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 TRAY (65219-056-29) / 50 mL in 1 VIAL (65219-056-09)
source: ndc

Packages (1)

Ingredients (2)

dibasic potassium phosphate (236 mg/mL) monobasic potassium phosphate (224 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "935c5395-1f0b-4277-97de-8b1cf1252d1e", "openfda": {"upc": ["0365219056096", "0365219052098", "0365219054092"], "unii": ["4J9FJ0HL51", "CI71S98N1Z"], "rxcui": ["1928567", "1928569", "2667657"], "spl_set_id": ["475f5cd7-45bd-412a-b419-9962585d6cda"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (65219-056-29)  / 50 mL in 1 VIAL (65219-056-09)", "package_ndc": "65219-056-29", "marketing_start_date": "20200210"}], "brand_name": "Potassium Phosphates", "product_id": "65219-056_935c5395-1f0b-4277-97de-8b1cf1252d1e", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Potassium Salt [EPC]"], "product_ndc": "65219-056", "generic_name": "Potassium Phosphate, Monobasic Potassium Phosphate, Dibasic", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Phosphates", "active_ingredients": [{"name": "DIBASIC POTASSIUM PHOSPHATE", "strength": "236 mg/mL"}, {"name": "MONOBASIC POTASSIUM PHOSPHATE", "strength": "224 mg/mL"}], "application_number": "NDA212832", "marketing_category": "NDA", "marketing_start_date": "20200210", "listing_expiration_date": "20261231"}